White label ELPA - ClinicalTrials.eu

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Not yet recruiting

3 1 1 1
Investigated diseases:
- Glioblastoma
Investigated drugs:
- Niraparib Tosilate Monohydrate
- Temozolomide
+2
Tambiciclib Added to Venetoclax and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia in Patients Who Did Not Respond After Two Treatment Cycles

Not yet recruiting

2 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Azacitidine
- Venetoclax
Early Saline Pleural Irrigation for Patients with Complicated Pleural Infections

Not yet recruiting

3 1 1 1
Investigated diseases:
- Infectious pleural effusion
Investigated drugs:
Letrozole During IVF/ICSI for Women with Endometriosis

Not yet recruiting

3 1 1 1
Investigated diseases:
- Endometriosis
Investigated drugs:
- Letrozole
Neoadjuvant Sacituzumab Govitecan and Pembrolizumab for Patients with Clinical Stage II-III Triple-Negative Early Breast Cancer

Not yet recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Sacituzumab Govitecan
- Pembrolizumab
Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Not yet recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Tislelizumab
- Docetaxel
+3
Efficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo

Not yet recruiting

2 1
Investigated diseases:
- Vitiligo
Study of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma

Not yet recruiting

3 1 1 1
Investigated diseases:
- Hodgkin’s disease
Investigated drugs:
Intravenous ferric carboxymaltose for drug‑resistant restless legs syndrome: a randomized delayed‑start trial in adults

Not yet recruiting

2 1 1 1
Investigated diseases:
- Restless legs syndrome
Investigated drugs:
- Ferric Carboxymaltose
Short‑course sublingual ITULAZAX birch pollen extract with Lactobacillus rhamnosus GG for patients with pollen‑associated food allergy

Not yet recruiting

2 1 1
Investigated diseases:
- Seasonal allergy
Investigated drugs:
- Betula Verrucosa (108)

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies